The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
Subscribe To Our Newsletter & Stay Updated
